• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于甲状腺滤泡细胞辐射剂量的Graves病131I治疗方案规划。

Planning of 131I therapy for graves disease based on the radiation dose to thyroid follicular cells.

作者信息

Eterovic Davor, Antunovic Zeljko, Markovic Vinko, Grosev Darko

机构信息

Department of Nuclear Medicine, University Hospital Split, University of Split Medical Faculty, Split, Croatia.

出版信息

J Nucl Med. 2008 Dec;49(12):2026-30. doi: 10.2967/jnumed.108.053934. Epub 2008 Nov 7.

DOI:10.2967/jnumed.108.053934
PMID:18997041
Abstract

UNLABELLED

We evaluated the effects on the absorbed dose to thyroid follicular cells of self-absorption of (131)I radiation (specifically, beta-rays) in the follicular colloid.

METHODS

Thyroid follicles were modeled as colloid-filled spheres, containing a uniform concentration of (131)I and surrounded by a concentric monolayer of cells. Assuming close packing of identical follicles, we used Monte Carlo simulation to assess the absorbed dose to follicular cells.

RESULTS

Because of beta-ray self-absorption in colloidal spheres with radii larger than 50 mum, the absorbed dose to follicular cells is less than the average thyroid absorbed dose.

CONCLUSION

For the same thyroid mass, radioiodine thyroid uptake, and effective half-life, patients with follicles with colloidal sphere radii of 100, 200, 300, and 400 microm should be administered 9%, 15%, 21%, and 30% more (131)I, respectively, than patients with colloidal sphere radii of less than 50 microm, to yield the same absorbed dose to follicular cells.

摘要

未标注

我们评估了滤泡胶体中¹³¹I辐射(具体为β射线)的自吸收对甲状腺滤泡细胞吸收剂量的影响。

方法

将甲状腺滤泡模拟为充满胶体的球体,球体中¹³¹I浓度均匀,周围有一层同心的单层细胞。假设相同滤泡紧密排列,我们使用蒙特卡罗模拟来评估滤泡细胞的吸收剂量。

结果

由于半径大于50μm的胶体球体内β射线的自吸收,滤泡细胞的吸收剂量低于甲状腺平均吸收剂量。

结论

对于相同的甲状腺质量、放射性碘甲状腺摄取量和有效半衰期,与胶体球半径小于50μm的患者相比,胶体球半径为100、200、300和400μm的滤泡患者,为使滤泡细胞获得相同的吸收剂量,应分别多给予9%、15%、21%和30%的¹³¹I。

相似文献

1
Planning of 131I therapy for graves disease based on the radiation dose to thyroid follicular cells.基于甲状腺滤泡细胞辐射剂量的Graves病131I治疗方案规划。
J Nucl Med. 2008 Dec;49(12):2026-30. doi: 10.2967/jnumed.108.053934. Epub 2008 Nov 7.
2
A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.一种用于计算接受¹³¹I治疗的格雷夫斯病甲状腺最终质量的预测数学模型。
Phys Med Biol. 2005 May 7;50(9):2181-91. doi: 10.1088/0031-9155/50/9/018. Epub 2005 Apr 20.
3
Possibility of limiting the un-justified irradiation in (131)I therapy of Graves' disease: a thyroid mass-reduction based method for the optimum activity calculation.限制(131)I 治疗格雷夫斯病时不合理照射的可能性:一种基于甲状腺体积减少的最佳活度计算方法。
Phys Med. 2010 Apr;26(2):71-9. doi: 10.1016/j.ejmp.2009.08.003. Epub 2009 Oct 2.
4
A dosimetric approach to patient-specific radioiodine treatment of Graves' disease with incorporation of treatment-induced changes in thyroid mass.一种针对格雷夫斯病患者特异性放射性碘治疗的剂量测定方法,纳入了治疗引起的甲状腺体积变化。
Med Phys. 2004 Jul;31(7):2121-7. doi: 10.1118/1.1763411.
5
Radioiodine therapy and thyrostatic drugs and iodine.放射性碘治疗、抗甲状腺药物与碘
Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S486-91. doi: 10.1007/s00259-002-0868-4. Epub 2002 Jun 27.
6
[Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance].[良性甲状腺疾病放射性碘治疗中的顿抑。定量及治疗相关性]
Nuklearmedizin. 2008;47(6):248-54.
7
CELLDOSE: a Monte Carlo code to assess electron dose distribution--S values for 131I in spheres of various sizes.CELLDOSE:一种用于评估电子剂量分布的蒙特卡罗代码——不同尺寸球体中¹³¹I的S值。
J Nucl Med. 2008 Jan;49(1):151-7. doi: 10.2967/jnumed.107.045179. Epub 2007 Dec 12.
8
Graves' disease radioiodine-therapy: choosing target absorbed doses for therapy planning.格雷夫斯病放射性碘治疗:为治疗计划选择目标吸收剂量
Med Phys. 2014 Jan;41(1):012503. doi: 10.1118/1.4846056.
9
A dosimetric algorithm for patient-specific 131I therapy of thyroid cancer based on a prescribed target-mass reduction.
Phys Med Biol. 2006 Dec 21;51(24):6449-56. doi: 10.1088/0031-9155/51/24/011. Epub 2006 Nov 30.
10
Radioiodine therapy for Graves disease: thyroid absorbed dose of 300 Gy-tuning the target for therapy planning.放射性碘治疗格雷夫斯病:甲状腺吸收剂量 300Gy-为治疗计划调整目标。
Clin Nucl Med. 2013 Apr;38(4):231-6. doi: 10.1097/RLU.0b013e3182816717.

引用本文的文献

1
Serum thyroxine and age--rather than thyroid volume and serum TSH--are determinants of the thyroid radioiodine uptake in patients with nodular goiter.血清甲状腺素和年龄——而不是甲状腺体积和血清 TSH——是结节性甲状腺肿患者甲状腺放射性碘摄取的决定因素。
J Endocrinol Invest. 2011 Mar;34(3):e52-7. doi: 10.1007/BF03347076. Epub 2010 Sep 9.
2
Reply to: Determinants of (131)I radiation dose to thyroid follicular cells.回复:甲状腺滤泡细胞(131)I辐射剂量的决定因素。
Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):1015-6. doi: 10.1007/s00259-009-1144-7.
3
Determinants of 131I radiation dose to thyroid follicular cells.
131I对甲状腺滤泡细胞辐射剂量的决定因素。
Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):721-2. doi: 10.1007/s00259-009-1088-y. Epub 2009 Feb 20.